Review Article

|

2015, 8(10): 3111–3140

|

https://doi.org/10.1007/s12274-015-0829-4

Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

Jianfeng Guo1, Kamil Rahme2,3,4, Kathleen A. Fitzgerald1, Justin D. Holmes3,4, and Caitriona M.O’Driscoll1 (*)

View Author's information

1 Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland 

2 Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh 1200, Lebanon 

3 Materials Chemistry and Analysis Group, Department of Chemistry and the Tyndall National Institute, University College Cork, Cork,Ireland 

4 Advanced Materials and BioEngineering Research (AMBER), Centre for Research on Adaptive Nanostructures and Nanodevices(CRANN), Trinity College Dublin, Dublin 2, Ireland


Keywords: siRNA delivery, RNA interference (RNAi)-based therapeutics, multifunctional nanoparticles, nanotoxicity of gold nanoparticles
Full article PDF
Cite this article(Endnote)
Share this article
Metric

views: 131

Citations: 0

  • Abstract
  • References
RNA interference (RNAi) effectors such as small interfering RNA (siRNA) and micro RNA (miRNA) can selectively downregulate any gene implicated in the pathology of a disease. Therefore, RNAi-based therapies have immense potential for the treatment of a wide range of diseases. However, pharmacokinetic and pharmacodynamic studies have revealed that these therapeutic agents have poor bioactivity due to a number of factors, including insufficient plasma drug levels, short plasma half-lives, renal clearance, and hepatic metabolism. Non-viral delivery may facilitate the clinical application of siRNA-based therapeutics by helping to overcome these barriers. Recently, the potential of gold nanoparticles (AuNPs) as multifunctional carriers for transporting drugs, proteins, and genetic materials has been demonstrated. In this review, some of the key properties of AuNPs relevant to siRNA delivery, such as physical properties and surface chemistry have been described. In addition, the ability of AuNP-based formulation strategies to successfully overcome delivery barriers associated with siRNA, and the potential for this material to translate into safe and effective nanomedicines are critically discussed.
Related Article
Cite this article

Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?. Nano Res. 2015, 8(10): 3111–3140 https://doi.org/10.1007/s12274-015-0829-4

Download citation